Adma Biologics Inc. (ADMA)
NASDAQ · Healthcare
Adma Biologics Inc. Operating Income 2020–2025
Adma Biologics Inc. annual/quarterly operating income history and growth rate from 2020 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Adma Biologics Inc. operating income for the quarter ending March 31, 2026 was 50.3 M, a 44.19% increase year-over-year.
- Adma Biologics Inc. operating income for the twelve months ending March 31, 2026 was 206.9 M.
- Adma Biologics Inc. annual operating income for 2025 was 191.4 M, a 37.75% increase from 2024.
- Adma Biologics Inc. annual operating income for 2024 was 139.0 M, a 542.49% increase from 2023.
- Adma Biologics Inc. annual operating income for 2023 was 21.6 M, a 154.95% decrease from 2022.
- Adma Biologics Inc. annual operating income for 2022 was -39.4 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Adma Biologics Inc. Operating Income — FAQ
Adma Biologics Inc. (ADMA) operating income over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
What is Adma Biologics Inc.'s operating income?
Adma Biologics Inc. (ADMA) reported operating income of $191M for fiscal 2025.
Where can I see ADMA's operating income history?
The chart and table above show Adma Biologics Inc.'s operating income by year and by quarter, including the growth rate.